Lorusso, D. Musacchio, L. Pignata, S. Braicu, E. I. and Cibula, D. Colombo, N. Frenel, J-S. Zagouri, F. Carbone, V. Ghizzoni, V. Giolitto, S. Giudice, E. Landolfo, C. and Perri, M. T. Ricci, C. Salutari, V. Scambia, G., Randomized phase III trial on niraparib - TSR-042 (dostarlimab) vs
physician's choice CHEmotherapy in recurrent ovarian, fallopian tube or
primary peritoneal cancer patients not candidate for platinum
retreatment: NItCHE trial (MITO 33), Annals of Oncology, (32), S768-S769, 2021, Elsevier, 0923-7534, 1569-8041